Clinical Trial Update: The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases [NA]

View source ↗

Summary

AstraZeneca is conducting a study to assess the prevalence, burden, and prognosis of chronic obstructive pulmonary disease in patients with cardiovascular disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Cardiovascular Diseases | NA | Status: RECRUITING